1. Home
  2. HNNA vs EPRX Comparison

HNNA vs EPRX Comparison

Compare HNNA & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNNA
  • EPRX
  • Stock Information
  • Founded
  • HNNA 1989
  • EPRX 2011
  • Country
  • HNNA United States
  • EPRX Canada
  • Employees
  • HNNA N/A
  • EPRX N/A
  • Industry
  • HNNA Investment Managers
  • EPRX
  • Sector
  • HNNA Finance
  • EPRX
  • Exchange
  • HNNA Nasdaq
  • EPRX NYSE
  • Market Cap
  • HNNA 94.7M
  • EPRX 109.7M
  • IPO Year
  • HNNA N/A
  • EPRX N/A
  • Fundamental
  • Price
  • HNNA $12.10
  • EPRX $3.65
  • Analyst Decision
  • HNNA
  • EPRX Strong Buy
  • Analyst Count
  • HNNA 0
  • EPRX 1
  • Target Price
  • HNNA N/A
  • EPRX $9.00
  • AVG Volume (30 Days)
  • HNNA 6.6K
  • EPRX 15.8K
  • Earning Date
  • HNNA 02-13-2025
  • EPRX 03-04-2025
  • Dividend Yield
  • HNNA 4.54%
  • EPRX N/A
  • EPS Growth
  • HNNA 75.66
  • EPRX N/A
  • EPS
  • HNNA 1.12
  • EPRX N/A
  • Revenue
  • HNNA $33,210,000.00
  • EPRX N/A
  • Revenue This Year
  • HNNA N/A
  • EPRX N/A
  • Revenue Next Year
  • HNNA N/A
  • EPRX N/A
  • P/E Ratio
  • HNNA $10.80
  • EPRX N/A
  • Revenue Growth
  • HNNA 38.27
  • EPRX N/A
  • 52 Week Low
  • HNNA $6.60
  • EPRX $2.20
  • 52 Week High
  • HNNA $13.88
  • EPRX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • HNNA 47.38
  • EPRX N/A
  • Support Level
  • HNNA $11.97
  • EPRX N/A
  • Resistance Level
  • HNNA $13.12
  • EPRX N/A
  • Average True Range (ATR)
  • HNNA 0.45
  • EPRX 0.00
  • MACD
  • HNNA -0.03
  • EPRX 0.00
  • Stochastic Oscillator
  • HNNA 26.62
  • EPRX 0.00

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: